TickerGuard
Buy Day today: Good (67) Broad market participation · no major macro event

Arvinas Inc (ARVN)

Healthcare Biotechnology
8.10 $
+0.4% vs. previous close
Closing price · As of: 3. Aug 2026

Arvinas Inc (ARVN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 718 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Balance Sheet ARVN
Tick rows to compare them in a chart (up to 4) 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
38 67 199 302 717 1,582 1,269 1,305 1,091 718
37 66 196 291 703 1,553 1,240 1,280 1,067 701
5.1 31 3.2 9.2 588 108 81 312 101 143
36 39 188 281 689 1,503 1,205 1,261 1,039 685
1.4 26 5.0 6.3 8.4 26 8.0 7.2 14 6.4
0.0 4.5 5.5
0.6 1.3 3.6 11 12 17 13
14 67 63 75 75 800 704 645 530 284
10 18 23 33 49 262 295 257 230 143
0.1 0.2 0.2 0.7 1.0 1.1 1.8 1.9 1.8 1.7
1.6 0.6 2.8 4.6 7.1 31 5.7 18 13 24
0.3 0.2 2.0 2.0 2.0 1.0 1.0 0.8 0.6 0.4
24 0.2 137 227 642 782 565 660 562 434
-34 -62 -302 -373 -492 -683 -965 -1,333 -1,532 -1,612
18 21 32 33 40 50 53 56 72 65

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?